Wollenberg, A., Flohr, C., Simon, D. et al. (30 more authors) (2020) European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis. Journal of the European Academy of Dermatology and Venereology, 34 (6). e241-e242. ISSN 0926-9959
Abstract
Atopic dermatitis (AD) is a complex disease with elevated risk of respiratory comorbidities. Severely affected patients are often treated with immune‐modulating systemic drugs. On March 11th 2020, the World Health Organization declared the 2019 novel coronavirus severe acute respiratory syndrome (SARS‐Cov‐2) epidemic to be a pandemic. The number of cases worldwide is increasing exponentially and poses a major health threat, especially for those who are elderly, immuno‐compromised, or have comorbidities. This also applies to AD patients on systemic immune‐modulating treatment. In these days of uncertainty, reallocation of medical resources, curfew, hoarding, and shutdown of normal social life, patients, caregivers and doctors ask questions regarding the continuation of systemic immune‐modulating treatment of AD patients. The ETFAD decided to address some of these questions here.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2020 European Academy of Dermatology and Venereology and John Wiley & Sons Ltd. This is an author-produced version of a paper subsequently published in Journal of the European Academy of Dermatology and Venereology. Uploaded in accordance with the publisher's self-archiving policy. |
Keywords: | COVID-19; SARS-CoV-2; atopic dermatitis; immunosuppressant; systemic therapy |
Dates: |
|
Institution: | The University of Sheffield |
Academic Units: | The University of Sheffield > Sheffield Teaching Hospitals |
Depositing User: | Symplectic Sheffield |
Date Deposited: | 01 Apr 2020 09:17 |
Last Modified: | 26 Nov 2021 15:55 |
Status: | Published |
Publisher: | Wiley |
Refereed: | Yes |
Identification Number: | 10.1111/jdv.16411 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:158966 |